On July 15, 2025, Aquestive Therapeutics announced that Health Canada has granted a meeting to discuss their New Drug Submission for Anaphylm™ (epinephrine) Sublingual Film, and they've submitted an initial briefing book to the EMA for a Marketing Authorization Application. This indicates progress in their drug approval process.